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Abstract
Background: Group A Streptococcus (GAS) causes acute tonsillopharyngitis in children, and approximately 20% of
this population are chronic carriers of GAS. Antibacterial therapy has previously been shown to be insufficient at
clearing GAS carriage. Bacterial biofilms are a surface-attached bacterial community that is encased in a matrix of
extracellular polymeric substances. Biofilms have been shown to provide a protective niche against the immune
response and antibiotic treatments, and are often associated with recurrent or chronic bacterial infections. The
objective of this study was to test the hypothesis that GAS is present within tonsil tissue at the time of
tonsillectomy.
Methods: Blinded immunofluorescent and histological methods were employed to evaluate palatine tonsils from
children undergoing routine tonsillectomy for adenotonsillar hypertrophy or recurrent GAS tonsillopharyngitis.
Results: Immunofluorescence analysis using anti-GAS antibody was positive in 11/30 (37%) children who had
tonsillectomy for adenotonsillar hypertrophy and in 10/30 (33%) children who had tonsillectomy for recurrent GAS
pharyngitis. Fluorescent microscopy with anti-GAS and anti-cytokeratin 8 & 18 antibodies revealed GAS was
localized to the tonsillar reticulated crypts. Scanning electron microscopy identified 3-dimensional communities of
cocci similar in size and morphology to GAS. The characteristics of these communities are similar to GAS biofilms
from in vivo animal models.
Conclusion: Our study revealed the presence of GAS within the tonsillar reticulated crypts of approximately one-
third of children who underwent tonsillectomy for either adenotonsillar hypertrophy or recurrent GAS
tonsillopharyngitis at the Wake Forest School of Medicine.
Trial Registration: The tissue collected was normally discarded tissue and no patient identifiers were collected.
Thus, no subjects were formally enrolled.
Background
Group A Streptococcus (GAS) is a b-hemolytic, Gram-
positive human pathogen capable of causing a wide vari-
ety of human disease. GAS is one of the predominant
causes of acute bacterial tonsillopharyngitis [1-6]. Ton-
sillopharyngitis is an acute infection of the palatine ton-
sils and pharynx often presenting symptomatically with
a sore throat, fever and cervical lymphadenopathy [7].
Patients diagnosed with GAS tonsillopharyngitis are pre-
scribed antibiotic therapy to avoid the potential develop-
ment of post-infectious sequelae such as acute
rheumatic fever and acute rheumatic heart disease [1-6].
Prevention of rheumatic fever with antibacterial ther-
apy can be life-saving, so it is important to identify
patients with GAS pharyngitis. Because accurate clinical
differentiation between viral and GAS pharyngitis is not
possible, laboratory confirmation of GAS pharyngitis is
recommended for children [8]. A common clinical pro-
blem occurs when patients frequently present with epi-
sodes of acute viral pharyngitis, but GAS is repeatedly
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because some of these children may be chronic carriers
of GAS. Approximately 20% of school-age children are
estimated to be chronic carriers of GAS, defined as pro-
longed persistence of GAS without evidence of infection
or an immune response [9]. Although chronic carriage
is well known and widespread, it is poorly understood
and its clinical relevance is unclear.
Antibacterial therapy sufficient to treat GAS pharyngi-
tis and prevent acute rheumatic fever is not effective in
eradicating GAS carriage [10,11]. There are a number of
hypotheses proposed to explain chronic GAS carriage.
1) Intracellular survival of GAS in tonsillar epithelium
has been reported [12,13]. 2) Non-GAS organisms pre-
sent in the pharynx that produce beta-lactamases may
confer antibacterial resistance to otherwise susceptible
GAS by proximity. 3) Carriage may occur due to an
absence of normal oral flora that inhibit GAS [14].
We have shown that GAS forms biofilms in vitro and
in vivo [15,16]. As put forth by Donlan and Costerton, a
biofilm is a bacterial sessile community encased in a
matrix of extracellular polymeric substances and
attached to a substratum or interface [17]. Biofilms are
inherently tolerant to host defenses and antibiotic thera-
pies and often involved in chronic or recurrent illness
due to impaired clearance [18,19]. It is estimated that
upwards of 60% of all bacterial infections involve bio-
films including dental caries, periodontitis, otitis media,
chronic tonsillitis, endocarditis, necrotizing fasciitis and
others [17,18,20]. Recently, bacterial biofilms have been
shown on the tonsillar surface although the colonizing
organism(s) has not been identified [21].
We sought to test the hypothesis that GAS biofilms
are present on pediatric tonsil samples after tonsillect-
omy thereby contributing to persistence of the organ-
ism. This study involved examination of the tonsillar
reticulated crypt epithelium, which is a branching net-
work throughout the palatine tonsil that increases sur-
face area and functions to allow more efficient antigen
sampling [22-24]. We used immunofluorescence to
demonstrate the presence of GAS within the reticulated
crypts of tonsils recovered from pediatric patients
undergoing tonsillectomy for recurrent GAS infection or
adenotonsillar hypertrophy (ATH). Scanning electron
microscopy and Gram-staining confirmed the presence
of biofilms of Gram-positive cocci on the surface of and
within tonsils recovered from both pediatric populations
(recurrent GAS tonsillopharyngitis and ATH) which had
tested positive for GAS by immunohistochemistry.
Methods
This study was approved by the Wake Forest University
Health Sciences Institutional Review Board. We ana-
lyzed specimens of tonsils from children 2-18 years of
age undergoing tonsillectomy for management of either
adenotonsillar hypertrophy (ATH) or recurrent GAS
infections in 2009-2010. Upon removal, tonsils were
placed in sterile PBS and kept at 4°C until processing.
One tonsil per child was prepared for immunofluores-
cence staining and three IF-positive samples underwent
scanning electron microscopy and tissue Gram-staining.
Clinical information without personal identifiers was
collected on a standardized form. It should be noted
that we did not have access to samples from patients
not requiring tonsillectomy. Thus, the cohort is biased
and findings may not be applicable to pediatric GAS
carriers that do not require such surgery.
Immunofluorescence
Processing
One palatine tonsil per child was fresh frozen in OCT
resin (Sakura Finetek, Torrance, CA) within a peel-a-
way disposable plastic tissue embedding mold (Poly-
sciences, Inc., Warrington, PA) and stored at -80°C.
Samples were acclimated to -20°C, cut into 10 μms e c -
tions with a cryotome, placed onto positively charged
microscope slides (Fisher Scientific, Fair Lawn, NJ), and
stored at -20°C until immunofluorescence staining. For
immunofluorescence staining, the slides were brought to
room temperature, briefly fixed with 4% paraformalde-
hyde-PBS (PFMA)(Sigma-Aldrich, St. Louis, MO), and
blocked for 30 min with 1% bovine serum albumin
(BSA)(Amresco, Solon, OH) to control for non-specific
antibody staining prior to addition of primary antibodies
at a 1 to 500 dilution.
Group A Streptococcus
Individual sections were stained with primary rabbit
anti-Streptococcus group A IgG (anti-GAS) (US Biologi-
cal, Swampscott, MA, #S7974-28) in 1% BSA-PBS for 30
min in a 37°C incubator. While the company certified
that the antibody does not react with other streptococ-
cal groups (including groups C, F and G), our own test-
ing confirmed the antibody did not cross-react with
group B Streptococcus,v i r i d a n sg r o u pStreptococcus nor
Streptococcus pneumoniae ( T i g r 4 )( d a t an o ts h o w n ) .
This anti-GAS antibody has been successfully used for
immunofluorescence previously by our group [16].
Tonsillar crypt epithelial
Cytokeratin 8 & 18 are co-expressed specifically by ton-
sillar crypt epithelial cells [22,25]. Individual sections
were stained with primary mouse monoclonal anti-Cyto-
keratin 8 and Cytokeratin 18 (Thermo Scientific, Fre-
mont, CA) in 1% BSA-PBS for 30 min in a 37°C
incubator.
Analysis
Individual sections were concurrently stained with anti-
body for GAS and for cytokeratin 8 & 18 to identify the
presence of GAS and determine if it was localized to the
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escence and non-specific antibody staining, adjacent
slides were either left unprobed with antibody or were
probed with a rabbit anti-Borrelia burgdorferi IgG, (US
Biological, Swampscott, MA) to control for IgG cross-
reactivity and non-specific binding. As a positive con-
trol, slides of GAS in vivo biofilm sections collected
from infected animals from a separate study [16] were
stained with rabbit anti-GAS. Secondary antibodies
((goat anti-rabbit IgG-Alexa 568) (Invitrogen Molecular
Probes, Eugene, OR) and goat anti-mouse-IgG-Alexa
488 (Invitrogen Molecular Probes, Eugene, OR)) were
applied and samples were incubated for 30 min in a 37°
C incubator. Samples were coated with ProLong Gold
antifade reagent (Invitrogen Molecular Probes, Eugene,
OR). Specific identification of GAS within the IF stained
tonsil material was primarily visualized using a Nikon
Eclipse TE300 Light Microscope equipped with an
EXFO Xcite 120 Illumination System (Nikon Instru-
ments Inc., Melville, NY) with a QImaging Retiga-EXi
camera (AES, Perth, Australia) and Image J software.
Gram-staining
Three tonsils that were positive for GAS by immuno-
fluorescence analysis also underwent analysis by Gram-
staining. Adjacent slides to those positive for immuno-
fluorescence were Gram-stained using the Taylor’s
Brown-Brenn modified Gram-stain procedure. Samples
were analyzed with a Nikon Eclipse TE300 Light
Microscope (Nikon Instruments, Inc., Melville, NY).
Images were taken using a QImaging Retiga-EXi cam-
era (AES, Perth, Australia) and stored through Image J
software.
Scanning electron microscopy
A portion of three immunofluorescence-positive GAS
tonsils from each group were fixed for 1 hour with 2.5%
glutaraldehyde-PBS and then rinsed twice for 10 min-
utes in PBS prior to dehydration in a graded ethanol
series. The samples were then subjected to critical point
drying, mounted onto stubs, and sputter coated with
palladium prior to viewing with a Philips SEM-515 scan-
ning electron microscope (FEI, Hillsboro, OR). As a
positive example of GAS biofilm formation on the sur-
face of tissue, excised skin epithelium from pigs colo-
nized ex vivo with GAS was processed and viewed as
described above.
Statistical Analysis
Categorical variables were analyzed by chi-square or
Fisher’s exact tests. A P-value of < 0.05 was considered
statistically significant. Stata 8.1 (Stata Corporation, Col-
lege Station, TX) was used for all analyses.
Results
Characteristics of study population undergoing
tonsillectomy
The children undergoing tonsillectomy ranged in age
from 2 years to 18 years with over half the children
being 5-13 years of age. The age groups, gender, and
race/ethnicity of children undergoing tonsillectomy for
recurrent GAS tonsillopharyngitis or for ATH were
similar (Table 1). Children undergoing tonsillectomy for
recurrent GAS tonsillopharyngitis were more likely to
have had a diagnosis of streptococcal pharyngitis in the
prior year and history of ear tube placement than those
with ATH.
Prevalence of GAS in pediatric tonsils after tonsillectomy
Overall, 21 (35%) of 60 tonsils were positive for GAS by
immunofluorescence. The proportion of tonsil samples
that had GAS detected by immunofluorescence with or
without acute symptoms of streptococcal pharyngitis
was similar for children undergoing surgery for ATH
(11 (37%) of 30 samples) and for those with recurrent
GAS infection (10 (33%) of 30 samples, P =0 . 7 9 ) .
Importantly, the anti-GAS antibody used does not
cross-react with other streptococcal groups (US Biologi-
cal, Swampscott, MA, #S7974-28).
Detection of GAS within the tonsillar crypts
We hypothesized that the detected GAS was localized in
the tonsillar crypts. Given that the reticulated crypt epithe-
lium expresses unique cytokeratin markers 8 & 18, we
elected to use dual staining immunofluorescence in an
effort to detect the colocalization of crypt markers with
GAS [22,25]. As proof of principle, the branching network
of the crypts was readily visible following staining with
anti-cytokeratin 8 and anti-cytokeratin 18 (Figure 1).
Dual staining immunofluorescence revealed that GAS
(RED) consistently localized to the tonsillar reticulated
crypt epithelium (GREEN) in both samples from recur-
rent GAS infection (Figure 2. row B, C) and ATH (Fig-
ure 3. row B, C, D) cases. Representative images of GAS
localization are shown (Figure 2, Figure 3). Positive con-
trols for the detection of GAS consisted of in vivo bio-
film samples collected from a chinchilla middle ear
model of GAS infection (Figure 2 and 3. row A) [16].
SEM detection of bacterial biofilms on the tonsillar
surface of samples positive for the presence of GAS
SEM was utilized to identify the presence of 3-dimen-
sional bacterial communities on the tonsillar surface
that are indicative of biofilms. As a positive control, we
used an established model in our laboratory of growing
GAS biofilms on pig skin. This model allows the devel-
opment of biofilms that are identical in appearance to
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infected middle ears of chinchillas and GAS infected
soft tissue of mice [16]. Excised skin epithelium from
pigs was incubated in the presence of GAS for a period
of 24 h and analyzed by SEM for the presence of bio-
films. As expected, distinct, 3-dimensional communities
of adherent chains of GAS cocci (biofilms) were
observed on the epithelium surface (Figure 4A, B). Close
inspection revealed the presence of extracellular matrix
material within the makeup of the biofilm (Figure 4A,
B). SEM revealed homologous biofilm structures on the
surface of tonsils that had previously tested positive for
the presence of GAS by immunofluorescence (Figure
4C-F). As in our positive controls, biofilms were not
evenly distributed across the tonsillar surface but rele-
gated to folds in the tonsil epithelium. While the size of
the biofilms differed from sample to sample, the overall
morphology of the structures observed were consistent
among samples from recurrent GAS infection (Figure
4 C ,D )a n dA T H( F i g u r e4 E ,F ) .C l o s ei n s p e c t i o n
revealed the presence of extracellular matrix associated
with the biofilms. We interpret this data as evidence of
GAS biofilms on the tonsil surface.
Gram-staining was utilized to provide further evidence of
Gram-positive biofilm formation
We and others have shown that adherent, 3-dimensional
microcolonies of bacteria within tissue visualized with
Table 1 Characteristics of study population undergoing tonsillectomy
a Characteristic Recurrent GAS pharyngitis Adenotonsillar hypertrophy
bP-value
Age group 0.67
< 5 yrs 8 (27%) 11 (38%)
5-13 yrs 19 (63%) 16 (55%)
> 13 yrs 3 (10%) 2 (7%)
Gender 0.51
% Female 14 (47%) 16 (55%)
% Male 16 (53%) 13 (45%)
Race/Ethnicity 0.10
White 22 (76%) 17 (55%)
Black 5 (17%) 8 (26%)
Hispanic 1 (3%) 6 (19%)
Black and White 1 (3%) 0 (0%)
GAS pharyngitis diagnosed within the past 12 months < 0.001
Yes 30 (100%) 5 (17%)
No 0 (0%) 24 (83%)
History of ear tubes 0.04
Yes 9 (31%) 2 (7%)
No 20 (69%) 27 (93%)
a There are 1 or 2 missing values for each category.
b Statistical Analysis. Categorical variables were analyzed by chi-square or Fisher’s exact tests. A P- value of < 0.05 was considered statistically significant. Stata 8.1
(Stata Corporation, College Station, TX) was used for all analyses.
Figure 1 Fluorescent antibody staining (10 μm sections) of Cytokeratin 8 & 18 (white) allows visualization of the tonsillar crypt
epithelium. Representative images of tonsils removed due to ATH (left) or recurrent GAS infection (right) are shown at 4 × magnification.
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film [16,21,26,27]. As further evidence of GAS biofilms in
the collected tissue, we next analyzed tonsillar tissue for
t h ep r e s e n c eo fm i c r o c o l o n i e sb yw a yo fG r a m - s t a i n i n g .
As a positive control for biofilm detection, we Gram-
stained specimens collected from a chinchilla that was
infected with GAS in the middle ear [16]. Biofilms of
GAS were clearly evident in addition to dispersed GAS
(Figure 5A). Homologous biofilms consisting of Gram-
positive cocci were observed in tonsil specimens collected
from children presenting with either recurrent GAS ton-
sillopharyngitis (Figure 5B) or ATH (Figure 5C, D).
Discussion
In the present study, we sought to test the hypothesis
that GAS was present within or on pediatric palatine
tonsils and to see if we could identify evidence of bio-
film formation. To achieve this, we analyzed surgically
excised tonsils from 30 pediatric patients undergoing
tonsillectomy due to recurrent GAS tonsillopharyngitis.
Originally, we planned to examine a limited number of
surgically excised tonsils from patients undergoing
tonsillectomy for ATH as these patients were asympto-
matic for GAS infection, and thus we thought these
samples would provide a negative control for the detec-
tion of GAS. However, we readily detected the presence
of GAS in these samples by immunofluorescence and
scanning electron microscopy revealed the presence of
biofilms made up of chains of cocci which morphologi-
cally resembled GAS. Given this result, we examined the
tonsils excised from a total of 30 patients presenting
with ATH in addition to the tonsils excised from 30
patients presenting with recurrent GAS
tonsillopharyngitis.
We discovered that a similar proportion of tonsils
from children with either ATH or recurrent GAS tonsil-
lopharyngitis were positive for GAS by immunofluores-
cence (~35% positive). Of note, our method of
immunofluorescence allowed the dual detection of both
GAS and the cellular markers of the reticulated crypt
epithelium, cytokeratin 8 & 18. By this method, we were
able to show that the GAS detected had colonized
throughout the tonsillar crypts in both sets of patient
tonsil samples.
Figure 2 Fluorescent antibody staining of GAS (red) within the crypts (green) of pediatric tonsils removed due to recurrent GAS
tonsillopharyngitis. (A) GAS within in vivo biofilm from a chinchilla. (B and C) GAS within the tonsillar crypts.
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ATH patients showed GAS in such a high percentage
was unexpected. However, bacterial carriage by chil-
dren with ATH is not unprecedented. Several previous
studies of adenotonsillar hypertrophy have provided
evidence that increased numbers of pathogenic bacteria
can be recovered from homogenized hypertrophic ton-
sil cores compared to swabs of those tonsils alone
[28,29]. Indeed, it is propos e dt h a tl y m p h o i dh y p e r p l a -
sia (chronic enlargement) is correlated with increased
bacterial load and increased B- and T-lymphocyte pro-
liferation [30,31]. This phenomenon has been
associated with a number of bacteria including Staphy-
loccocus aureus, Haemophilus influenzae, S. pneumo-
niae, as well as GAS [28]. However, a review of the
literature revealed that the percentage of hypertrophic
tonsils positive for GAS by Brodsky et al. (16%) and
Stjernquist-Desatnik et al. (20%) was lower than the
36.7% positive that we observed [28,32]. Our method
of detection is more sensitive (antibody based immu-
nofluorescence vs. culture), but this difference in fre-
quency of detection may also be due to geographic
location or the fact that our study occurred almost 20
years after the reports referenced.
Figure 3 Fluorescent antibody staining of GAS (red) within the crypts (green) of pediatric tonsils removed due to ATH.( A) GAS within
in vivo biofilm from a chinchilla. (B, C, D) GAS within the tonsillar crypts.
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pediatric palatine tonsils as a biofilm. SEM clearly
reveals the presence of 3-dimensional communities of
chains of cocci in tonsils that had tested positive for the
presence of GAS by immunofluorescence. These struc-
tures closely resemble the in vivo GAS biofilms grown
ex vivo on pig epithelium. Furthermore, Gram-staining
reveals the presence of microcolonies of Gram-positive
cocci indicative of biofilms in samples that tested posi-
tive for the presence of GAS. However, despite the fact
that these samples were positive for GAS by immuno-
fluorescence, we cannot rule out at this juncture that
the biofilms observed by SEM or Gram-staining were
not GAS.
Detailed information regarding antibiotic exposure
prior to tonsillectomy was not collected; however, it is
known that 100% of the children undergoing tonsillect-
omy for recurrent GAS tonsillopharyngitis had experi-
enced a recent GAS infection. The finding that GAS
were detected in roughly equivalent percentages in these
two patient groups is consistent with the hypothesis that
biofilms may be important in carrier state antibacterial
resistance.
The high rate of asymptomatic GAS colonization that
is presented here also has implications regarding the uti-
lity of rapid antigen tests and cell culture. The question
of what is a true positive vs. a clinical false positive,
especially in light of the potential for co-colonization by
a viral pathogen, is a difficult one. Now that we have
established the ability to rapidly detect the presence of
GAS within the tonsillar crypt, our emphasis will turn
to the collection and typing of these strains, analysis of
the frequency of their isolation, as well as an elucidation
of what makes up the GAS biofilm structure and how it
is regulated. Specifically, our findings contribute to an
understanding of GAS tonsillar colonization. Developing
the capacity to distinguish patients with GAS tonsillo-
pharyngitis from those with GAS colonization, or those
with GAS colonization and viral tonsillopharyngitis is a
clinically important goal that could greatly reduce
Figure 4 SEM showing chains of adherent cocci organized into biofilms attached to the surface of pig skin epithelium (A and B) and
to the surface of a tonsil removed due to recurrent GAS infection (C and D) or ATH (E and F).
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contribute to the development of clinically useful meth-
ods for identifying patients with longstanding GAS
colonization.
Conclusions
Our study revealed the presence of GAS within the ton-
sillar reticulated crypts of approximately one-third of
children who underwent tonsillectomy for either adeno-
tonsillar hypertrophy or recurrent GAS tonsillopharyngi-
tis at the Wake Forest School of Medicine.
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